Menu
Recruiting NCT06062693

New Interactive Sensor-home-based Hand Training to Improve Dexterity

No phase Interventional Stroke Multiple Sclerosis Parkinson Disease

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: smart sensor egg training.
Who it may be relevant to
Registry conditions: Stroke, Multiple Sclerosis, Parkinson Disease. Basic parameters: 18 years — 99 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Switzerland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

Primary objective of this study is to explore the impact of a 3-week upper limb hand function training in patients with PD, MS or stroke. The benefits on hand function of this training program will be evaluated. The hypothesize is that the 3-week upper limb hand function training improves finger dexterity.

Detailed description

Patients with Parkinson's disease (PD), multiple sclerosis (MS) or stroke often suffer from significantly decreased coordination and have difficulties with precise hand/finger movements during the performance of both basic activities of daily living (ADL), such as dressing, grooming as well as higher ADL, such as cooking, shopping and regular medication intake. The investigators explore the effects of a new, interactive, sensor-home-based upper limb hand training on upper limb related ADL in patients with PD, MS or stroke.

Interventions

  • Device smart sensor egg training
    The portable hand trainer has three principal functionalities: (I) Grasping, (II) Pronosupination, and (III) wrist and finger extension. Different exercises can be done.

Primary outcome measures

  • hand dexterity [Time frame: 3 weeks]
Secondary outcome measures (8)
  • fine finger movements [Time frame: 3 weeks]
  • grip strength [Time frame: 3 weeks]
  • cognition [Time frame: baseline]
  • executive function [Time frame: 3 weeks]
  • executive function [Time frame: 3 weeks]
  • self-reported dexterity related problems in daily living for PD [Time frame: 3 weeks]
  • self-reported arm and hand function related problems in patients with MS [Time frame: 3 weeks]
  • Arm and hand function in stroke patients [Time frame: 3 weeks]

Eligibility criteria

Inclusion criteria

  • Patients with confirmed PD, according to UK Brain bank Criteria (Hughes et al., 1992) or
  • MS patients with relapsing-remitting MS (RRMS), secondary-progressive MS (SPMS) or primary progressive MS (PPMS) according to the revised McDonald's criteria or
  • subacute stroke
  • written and signed informed consent
  • self-reported hand function problems

or

  • healthy subject
  • written and signed informed consent
  • no self-reported hand function problems

Exclusion criteria

  • MoCA <21/30
  • psychiatric disease
  • participation on other interventional trials
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Switzerland · 1 center
  • Luzerner Kantonsspital — Lucerne

Identifiers

NCT: NCT06062693 · 2022-02300

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗